Skip to main content
. 2023 Feb 24;4(2):381–392. doi: 10.1002/jha2.663

FIGURE 3.

FIGURE 3

Heat map of mutations in venetoclax‐sensitive and venetoclax‐resistant patients. Patients that achieved complete remission (CR), CR with incomplete hematologic recovery (CRi), or CR with partial hematologic recovery (CRh) are shown in the left panel. Patients that were refractory to venetoclax, died during treatment, or had an evaluable response that was no better than a morphological leukemia‐free state are shown in the right panel.